Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Marco Chiarini"'
Autor:
Marco Vignetti, Alessandro M. Vannucchi, Francesco Mannelli, Sergio Amadori, Francesco Buccisano, Giacomo Gianfaldoni, Roberto Caporale, Paola Fazi, Maria Teresa Voso, Giuseppe Rossi, Paola Guglielmelli, Adriano Venditti, Enrico Crea, Marco Chiarini, Alfonso Piciocchi
Publikováno v:
Future Oncology. 17:3787-3796
AMELIORATE is a Phase III, randomized trial aiming to personalize treatment intensity in FLT3-mutated acute myeloid leukemia. The current study provides an early appraisal of chemosensitivity based on peripheral blasts clearance, as assessed by multi
Autor:
Alessandra Tucci, Chiara Cattaneo, Valentina Angelini, Annalisa Peli, Angelo Belotti, Luigi Grazioli, Giulia Vittoria Facchetti, Alberta Villanacci, Monica Micilotta, Rossella Ribolla, Aldo M. Roccaro, Chiara Bottelli, Samantha Ferrari, Barbara Frittoli, Claudia Crippa, Marco Chiarini, Viviana Giustini, Giuseppe Rossi, Valeria Cancelli
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 17, Pp 5859-5865 (2021)
Cancer Medicine, Vol 10, Iss 17, Pp 5859-5865 (2021)
Background Diffusion‐weighted whole‐body MRI (DW‐MRI) is increasingly used in the management of multiple myeloma (MM) patients, but data regarding the prognostic role of DW‐MRI imaging response after treatment are lacking. The Myeloma Respons
Autor:
Marta Zaffira Conti, Luisa Imberti, Federico Serana, Andrea Visconti, Marco Chiarini, Valentina Torri Clerici, Diego Bertoli, Marco Rovaris, Claudio Solaro, Viviana Giustini, Diana Ferraro, Simonetta Galgani, Ruggero Capra, Alessandra Sottini, Cristina Scarpazza
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-11 (2020)
Journal of Translational Medicine
Journal of Translational Medicine
Background The mechanisms underlying the therapeutic activity of interferon-β in multiple sclerosis are still not completely understood. In the present study, we evaluated the short and long-term effects of interferon-β treatment on different subse
Autor:
Canessa Clementina, Raffaele Badolato, Stefano Rossi, Boaz Palterer, Francesco Saettini, Marco Chiarini, Daniele Moratto, Antonio Marzollo, Alessandro Plebani, Lodi Lorenzo, Manuela Baronio, Silvia Ricci, Alessandra Sottini, Luisa Gazzurelli, Luisa Imberti, Daniele Zama, Chiara Gorio, Linda Rossini, Vassilios Lougaris
Publikováno v:
Journal of clinical immunology. 42(2)
Purpose Jacobsen syndrome (JS) is a rare form of genetic disorder that was recently classified as a syndromic immunodeficiency. Available detailed immunological data from JS patients are limited. Methods Clinical and immunological presentation of twe
Autor:
Giulia Baresi, Mauro Giacomelli, Daniele Moratto, Marco Chiarini, Immacolata Claudia Conforti, Rita Padoan, Piercarlo Poli, Silviana Timpano, Francesca Caldarale, Raffaele Badolato
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Frontiers in Pediatrics
Frontiers in Pediatrics
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we en
Autor:
Samantha Ferrari, Chiara Cattaneo, Chiara Bottelli, Claudia Crippa, Rossella Ribolla, Aldo M. Roccaro, Valeria Cancelli, Giuseppe Rossi, Annalisa Peli, Alessandra Tucci, Viviana Giustini, Marco Chiarini, Angelo Belotti
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S36-S37
Background sustained MRD negativity is emerging as a surrogate biomarker of patients (pts)’ outcome in clinical trials. We implemented this tool in our clinical practice and we analyzed outcome according to sustained MRD negativity in MM pts treate
Autor:
Maria Rosa Pozzi, Maria Bianchi Janetti, Marco Chiarini, Daniele Moratto, Vassilios Lougaris, Manuela Baronio, Alessandro Plebani, Luisa Gazzurelli
Publikováno v:
Clinical Immunology (Orlando, Fla.)
Clinical Immunology
Clinical Immunology
Highlights • This study describes for the first time the clinical course of SARS-CoV-2 infection in a male patient with Good's syndrome. • Absence of peripheral B cells may not always correlate with mild clinical course of COVID-19. • Immunolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f886ca41fc4d545a73348eabbfd2a738
http://hdl.handle.net/11379/539318
http://hdl.handle.net/11379/539318
Autor:
Francesco Saettini, Grazia Fazio, Daniele Moratto, Marta Galbiati, Nicola Zucchini, Davide Ippolito, Marco Emilio Dinelli, Luisa Imberti, Mario Mauri, Maria Luisa Melzi, Sonia Bonanomi, Alessio Gerussi, Marinella Pinelli, Chiara Barisani, Cristina Bugarin, Marco Chiarini, Mauro Giacomelli, Rocco Piazza, Giovanni Cazzaniga, Pietro Invernizzi, Silvia Clara Giliani, Raffaele Badolato, Andrea Biondi
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
DOCK8 deficiency is a combined immunodeficiency due to biallelic variants in dedicator of cytokinesis 8 (DOCK8) gene. The disease has a wide clinical spectrum encompassing recurrent infections (candidiasis, viral and bacterial infections), virally dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de10be0017664ba27d2774e895387bf
http://hdl.handle.net/10281/336789
http://hdl.handle.net/10281/336789
Autor:
Francesca Caldarale, Mauro Giacomelli, Emirena Garrafa, Nicola Tamassia, Alessia Morreale, Piercarlo Poli, Silviana Timpano, Giulia Baresi, Fiammetta Zunica, Marco Cattalini, Daniele Moratto, Marco Chiarini, Elvira Stefania Cannizzo, Giulia Marchetti, Marco Antonio Cassatella, Andrea Taddio, Alberto Tommasini, Raffaele Badolato
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
BackgroundSARS-CoV-2 occurs in the majority of children as COVID-19, without symptoms or with a paucisymptomatic respiratory syndrome, but a small proportion of children develop the systemic Multi Inflammatory Syndrome (MIS-C), characterized by persi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58d292cac3d93304b53e7bd954fa2e3
https://hdl.handle.net/11562/1082809
https://hdl.handle.net/11562/1082809
Autor:
Laura Palumbo, Luisa Gazzurelli, Marco Chiarini, Michael Colpani, Gaetana Lanzi, Maria Federica Girelli, Letizia Brescia, Giorgio Costagliola, Maria Cristina Menconi, Vassilios Lougaris, Alessio Benvenuto, Laura Luti, Maria Pia Bondioni, Raffaele Badolato, Gabriella Casazza, Antonella Meini, Giulio Tessarin, Silvia Giliani, Manuela Baronio, Fiammetta Zunica, Alessandro Plebani, Stefano Rossi, Fabio Cardinale, Daniele Moratto, Francesco Saettini, Baldassarre Martire
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 10
Journal of Clinical Medicine, Vol 9, Iss 3335, p 3335 (2020)
Volume 9
Issue 10
Journal of Clinical Medicine, Vol 9, Iss 3335, p 3335 (2020)
Activated phosphoinositide 3-kinase delta syndrome 1 (APDS-1) is a recently described inborn error of immunity caused by monoallelic gain-of-function mutations in the PIK3CD gene. We reviewed for the first time medical records and laboratory data of